'I was floored by the data': Psilocybin shows anti-aging properties in early study

 

Well, hasn't your competent? doctor already prescribed various types of psychedelics to get you recovered? 

What about all these drugs for stroke recovery? Doesn't your doctor read the literature?

DMT (8 posts to November 2020)

ecstasy (19 posts to November 2012)

LSD (5 posts to September 2018)

CerAxon (5 posts to January 2012)

citicoline (15 posts to October 2011)

magic mushrooms (10 posts to October 2014) 

psilocybin (14 posts to May 2014)

Psychedelics (25 posts to August 2018)

My 13 reasons for marijuana use post-stroke.  

Don't follow me, I'm not medically trained, and I don't have a Dr. in front of my name. 

The latest here:

'I was floored by the data': Psilocybin shows anti-aging properties in early study

Psilocybin, the main psychoactive ingredient in magic mushrooms, extends the lifespan of human cells, a lab study suggests. Researchers also found that the psychedelic compound slows certain hallmarks of aging in older mice while improving their fur quality.

The findings, published July 8 in the journal npj Aging, provide the first experimental evidence of psilocybin's potential anti-aging properties.

"The study provides a unique look at the potential of psychedelics to promote healthy aging and provides a provocative mechanism to explain how they do it," Scott Thompson, a professor in the University of Colorado Department of Psychiatry who was not involved in the research, told Live Science in an email.

You may like

• Combo of cancer therapy drugs increases mice lifespan by 30%
• New study raises big questions about taurine as anti-aging supplement

College student discovers psychedelic fungus that eluded LSD inventor

However, "much additional work will be required to take these findings forward in a way that will reveal whether or not the findings are applicable and adaptable for human health," Thompson said.

Recently, studies have explored psilocybin's therapeutic potential for treating various conditions, such as anxiety, depression and neurodegenerative disorders like Alzheimer's disease. Some of this research has led to clinical trials with promising results. But researchers haven't yet pinned down exactly how the psychedelic achieves its benefits.

One theory, dubbed the "psilocybin-telomere hypothesis," proposes that psilocybin preserves the length of telomeres, the protective caps of repetitive DNA sequences located at the ends of chromosomes. Researchers have long understood that telomeres shorten with age, and the rate of that shortening correlates to the rate of aging.

Related: 'Magic mushroom' compound creates a hyper-connected brain to treatdepression

forward in a way that will reveal whether or not the findings are applicable and adaptable for human health," Thompson said.